Mingheng Liao

2.3k total citations · 2 hit papers
42 papers, 1.5k citations indexed

About

Mingheng Liao is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Mingheng Liao has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 15 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Mingheng Liao's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mingheng Liao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mingheng Liao collaborates with scholars based in China, Taiwan and Ethiopia. Mingheng Liao's co-authors include Jiwei Huang, Kefei Yuan, Yong Zeng, Lin Xu, Hong Wu, Kunlin Xie, Yong Zeng, Xi Chen, Tian Lan and Jiaxin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Mingheng Liao

42 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3

2019 349 citations Tian Lan, Lin Xu et al. Molecular Cancer profile →
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics

2025 20 citations Xiao Ma, Tengda Huang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingheng Liao China	21	739	584	399	284	256	42	1.5k
Weijia Liao China	21	663 0.9×	445 0.8×	328 0.8×	360 1.3×	128 0.5×	64	1.3k
Hong Yu China	20	675 0.9×	504 0.9×	506 1.3×	451 1.6×	561 2.2×	63	1.8k
Stefano Caruso France	28	969 1.3×	687 1.2×	391 1.0×	471 1.7×	198 0.8×	55	1.9k
Giorgia Marisi Italy	23	603 0.8×	616 1.1×	423 1.1×	478 1.7×	126 0.5×	71	1.4k
Ying‐Hao Shen China	23	571 0.8×	418 0.7×	499 1.3×	413 1.5×	270 1.1×	75	1.5k
Zhan‐Hong Chen China	22	1.0k 1.4×	838 1.4×	227 0.6×	555 2.0×	198 0.8×	65	1.9k
Lechi Ye China	18	589 0.8×	511 0.9×	354 0.9×	628 2.2×	241 0.9×	48	1.4k
Miguel Albuquerque France	19	333 0.5×	258 0.4×	486 1.2×	238 0.8×	192 0.8×	39	1.2k
Yihong Ling China	21	346 0.5×	240 0.4×	355 0.9×	354 1.2×	261 1.0×	58	1.2k
Wenlong Yu China	22	484 0.7×	438 0.8×	134 0.3×	316 1.1×	381 1.5×	50	1.2k

Countries citing papers authored by Mingheng Liao

Since Specialization

Citations

This map shows the geographic impact of Mingheng Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingheng Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingheng Liao more than expected).

Fields of papers citing papers by Mingheng Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingheng Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingheng Liao. The network helps show where Mingheng Liao may publish in the future.

Co-authorship network of co-authors of Mingheng Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingheng Liao. A scholar is included among the top collaborators of Mingheng Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingheng Liao. Mingheng Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Xiao, Tengda Huang, Xi Chen, et al.. (2025). Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics. Signal Transduction and Targeted Therapy. 10(1). 63–63. 20 indexed citations breakdown →

Liao, Haotian, Haichuan Wang, Youpei Lin, et al.. (2024). Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers. Cancer Research. 84(11). 1747–1763. 7 indexed citations

Du, Jinpeng, Lian Li, Qingbo Feng, et al.. (2023). CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 125–125. 20 indexed citations

Liao, Mingheng, et al.. (2023). Transhepatic arterial approaches for ICG injection to guide laparoscopic anatomical hepatectomy: A case series study. Asian Journal of Surgery. 47(2). 916–922. 1 indexed citations

Du, Jinpeng, Zhen Wang, Qingbo Feng, et al.. (2022). The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma. International Journal of Cancer. 151(3). 337–347. 23 indexed citations

Chen, Xing, Liangqing Dong, Lu Chen, et al.. (2022). Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies. HepatoBiliary Surgery and Nutrition. 12(4). 478–494. 1 indexed citations

Du, Jinpeng, Tian Lan, Haotian Liao, et al.. (2022). CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma. Molecular Cancer. 21(1). 18–18. 49 indexed citations

Feng, Qingbo, Chuang Jiang, Xuping Feng, et al.. (2021). Robotic Versus Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 752236–752236. 11 indexed citations

Feng, Qingbo, Hongyu Jin, Jinpeng Du, et al.. (2021). Laparoscopic Pancreaticoduodenectomy Versus Conventional Open Approach for Patients With Pancreatic Duct Adenocarcinoma: An Up-to-Date Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 749140–749140. 11 indexed citations

10.

Yao, Yutong, Haotian Liao, Jiwei Huang, et al.. (2021). Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma. Annals of Translational Medicine. 9(10). 861–861. 3 indexed citations

11.

Jiang, Chuang, Gong Cheng, Mingheng Liao, & Jiwei Huang. (2021). Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. World Journal of Surgical Oncology. 19(1). 81–81. 37 indexed citations

12.

Liao, Haotian, Tian‐Yuan Xiong, Jiajie Peng, et al.. (2020). Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning. Annals of Surgical Oncology. 27(7). 2359–2369. 45 indexed citations

13.

Luo, Lin, Qin Han, Zexin Zhu, et al.. (2018). Exosomal MicroRNA-10a Is Associated with Liver Regeneration in Rats through Downregulation of EphA4. Chinese Medical Journal. 131(4). 454–460. 12 indexed citations

14.

Xie, Kunlin, Lin Xu, Hao Wu, et al.. (2017). OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis. OncoImmunology. 7(4). e1404214–e1404214. 60 indexed citations

15.

Liao, Mingheng, Zexin Zhu, Haichuan Wang, & Jiwei Huang. (2017). Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology. 52(6-7). 624–634. 51 indexed citations

16.

Liao, Mingheng, Jingyi Zhang, Yang Liu, et al.. (2017). Radiofrequency ablation using a 10‐mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial. Journal of Surgical Oncology. 115(8). 971–979. 39 indexed citations

17.

Zhu, Zexin, Jiwei Huang, Mingheng Liao, & Yong Zeng. (2016). Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection. Japanese Journal of Clinical Oncology. 46(12). 1075–1080. 52 indexed citations

18.

Liao, Mingheng, Tao Zhang, Haichuan Wang, et al.. (2016). Rabbit model provides new insights in liver regeneration after transection with portal vein ligation. Journal of Surgical Research. 209. 242–251. 6 indexed citations

19.

Huang, Jiwei, Lünan Yan, Hong Wu, et al.. (2015). Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?. Journal of Surgical Research. 200(1). 122–130. 36 indexed citations

20.

Huang, Jiwei, Wei Tang, Roberto Hernandez‐Alejandro, et al.. (2014). Intermittent Hepatic Inflow Occlusion During Partial Hepatectomy for Hepatocellular Carcinoma Does Not Shorten Overall Survival or Increase the Likelihood of Tumor Recurrence. Medicine. 93(28). e288–e288. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact